Preconditioning Strategy in Stem Cell Transplantation Therapy

Translational Stroke Research

Volumn 4, Issue 1, 2013, Pages 76-88

  Yu, Shan Ping ^a,b   Wei, Zheng ^b   Wei, Ling ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Heart attack; Ischemia; Neurodegenerative disorder; Stem cell preconditioning; Stroke

Indexed keywords

GAP JUNCTION PROTEIN; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1;

BRAIN ISCHEMIA; CELL HOMING; CELL MIGRATION; CELL REGENERATION; CELL SURVIVAL; CELL TYPE; CEREBROVASCULAR ACCIDENT; DEGENERATIVE DISEASE; DOWN REGULATION; GAP JUNCTION; HUMAN; HYPOXIA; IMMUNE RESPONSE; IN VITRO STUDY; ISCHEMIC PRECONDITIONING; MITOCHONDRION; NERVE CELL DIFFERENTIATION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION;

HEART ATTACK; ISCHEMIA; NEURODEGENERATIVE DISORDER; STEM CELL PRECONDITIONING; STROKE;

ANIMALS; BRAIN; BRAIN INFARCTION; HUMANS; ISCHEMIC PRECONDITIONING; MICE; MITOCHONDRIA; RATS; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION;

EID: 84872650118     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-012-0251-0     Document Type: Review

References (157)

1. Deveau T, Yu SP, Wei L. Cellular therapy for ischemic stroke. In: Lapchak PA, Zhang JH, editors. Translational stroke research: from target selection to clinical trials. New York: Springer; 2012. p. 777-814.
2. Doorn J, Moll G, Le Blanc K, van Blitterswijk C, de Boer J. Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements. Tissue Eng Part B Rev. 2012; 18: 101-15.
3. Haider KH, Ashraf M. Preconditioning approach in stem cell therapy for the treatment of infarcted heart. Prog Mol Biol Transl Sci. 2012; 111: 323-56.
4. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis. 2009; 204: 334-41.
5. Perez-Pinzon MA. Mechanisms of neuroprotection during ischemic preconditioning: lessons from anoxic tolerance. Comp Biochem Physiol Mol Integr Physiol. 2007; 147: 291-9.
6. Grimm C, Wenzel A, Groszer M, Mayser H, Seeliger M, Samardzija M, et al. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med. 2002; 8: 718-24.
7. Trendelenburg G, Dirnagl U. Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia. 2005; 50: 307-20.
8. Ran R, Xu H, Lu A, Bernaudin M, Sharp FR. Hypoxia preconditioning in the brain. Dev Neurosci. 2005; 27: 87-92.
9. Li, Y, Yu, SP, Mohamad, O, Genetta, T, Wei, L, Sublethal Transient Global Ischemia Stimulates Migration of Neuroblasts and Neurogenesis in Mice. In: Translational stroke research. New York: Springer; 2010. p. 184-196.
10. Przyklenk K, Whittaker P. Remote ischemic preconditioning: current knowledge, unresolved questions, and future priorities. J Cardiovasc Pharmacol Ther. 2011; 16: 255-9.
11. Fairbanks SL, Brambrink AM. Preconditioning and postconditioning for neuroprotection: the most recent evidence. Best Pract Res Clin Anaesthesiol. 2010; 24: 521-34.
12. Koch S, Katsnelson M, Dong CH, Perez-Pinzon M. Remote ischemic limb preconditioning after subarachnoid hemorrhage a phase Ib study of safety and feasibility. Stroke. 2011; 42: 1387-91.
13. Dirnagl U, Becker K, Meisel A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol. 2009; 8: 398-412.
14. Hu XY, Yu SP, Fraser JL, Lu ZY, Ogle ME, Wang JA, et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg. 2008; 135: 799-808.
15. Wei L, Fraser JL, Lu ZY, Hu XY, Yu SP. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol Dis. 2012; 46: 635-45.
16. Theus MH, Wei L, Cui L, Francis K, Hu XY, Keogh C, et al. In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Exp Neurol. 2008; 210: 656-70.
17. Ogle ME, Yu SP, Wei L. Primed for lethal battle: a step forward to enhance the efficacy and efficiency of stem cell transplantation therapy. J Thorac Cardiovasc Surg. 2009; 138: 527-7.
18. Ii M, Nishimura H, Iwakura A, Wecker A, Eaton E, Asahara T, et al. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Circulation. 2005; 111: 1114-20.
19. Yan FD, Yao YY, Chen LJ, Li YF, Sheng ZL, Ma GS. Hypoxic preconditioning improves survival of cardiac progenitor cells: role of stromal cell derived factor-1 alpha-CXCR4 axis. PLoS One. 2012; 7: 9.
20. Stubbs SL, Hsiao STF, Peshavariya HM, Lim SY, Dusting GJ, Dilley RJ. Hypoxic preconditioning enhances survival of human adipose-derived stem cells and conditions endothelial cells in vitro. Stem Cells Dev. 2012; 21: 1887-96.
21. Aly A, Peterson KM, Lerman A, Lerman LO, Rodriguez-Porcel M. Role of oxidative stress in hypoxia preconditioning of cells transplanted to the myocardium: a molecular imaging study. J Cardiovasc Surg. 2011; 52: 579-85.
22. Peterson KM, Aly A, Lerman A, Lerman LO, Rodriguez-Porcel M. Improved survival of mesenchymal stromal cell after hypoxia preconditioning: role of oxidative stress. Life Sci. 2011; 88: 65-73.
23. Das R, Jahr H, van Osch G, Farrell E. The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches. Tissue Eng Part B Rev. 2010; 16: 159-68.
24. Wang JA, He A, Hu XY, Jiang Y, Sun Y, Jiang J, et al. Anoxic preconditioning: a way to enhance the cardioprotection of mesenchymal stem cells. Int J Cardiol. 2009; 133: 410-2.
25. Li JH, Zhang N, Wang JA. Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchyma stem cells by anoxic pre-conditioning in diabetic cardiomyopathy. J Endocrinol Investig. 2008; 31: 103-10.
26. He AN, Jiang Y, Gui C, Sun Y, Li JH, Wang JA. The antiapoptotic effect of mesenchymal stem cell transplantation on ischemic myocardium is enhanced by anoxic preconditioning. Can J Cardiol. 2009; 25: 353-8.
27. Xie XX, Sun AJ, Zhu WQ, Huang ZY, Hu XY, Jia JG, et al. Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats. Tohoku J Exp Med. 2012; 226: 29-36.
28. Zhang J, Chen G-H, Wang Y-W, Zhao J, Duan H-F, Liao L-M, et al. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's jelly mesenchymal stem cells after myocardial infarction. Chin Med J. 2012; 125: 3472-8.
29. Kondo-Nakamura M, Shintani-Ishida K, Uemura K, Yoshida K. Brief exposure to carbon monoxide preconditions cardiomyogenic cells against apoptosis in ischemia-reperfusion. Biochem Biophys Res Commun. 2010; 393: 449-54.
30. Li Y, Lu ZY, Keogh CL, Yu SP, Wei L. Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J Cereb Blood Flow Metab. 2007; 27: 1043-54.
31. Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res. 2008; 77: 134-42.
32. Zemani F, Silvestre JS, Fauvel-Lafeve F, Bruel A, Vilar J, Bieche I, et al. Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arterioscler Thromb Vasc Biol. 2008; 28: 644-50.
33. Chen J, Du XL, Zhang KL. Effects of stromal-derived factor 1 preconditioning on apoptosis of rat bone mesenchymal stem cells. J Huazhong Univ Sci Tech-Med Sci. 2009; 29: 423-6.
34. Lu G, Ashraf M, Haider KH. Insulin-like growth factor-1 preconditioning accentuates intrinsic survival mechanism in stem cells to resist ischemic injury by orchestrating protein kinase C alpha-Erk1/2 activation. Antioxid Redox Signal. 2012; 16: 217-27.
35. Tilkorn DJ, Davies EM, Keramidaris E, Dingle AM, Gerrand YW, Taylor CJ, et al. The in vitro preconditioning of myoblasts to enhance subsequent survival in an in vivo tissue engineering chamber model. Biomaterials. 2012; 33: 3868-79.
36. Jiang BM, Xiao WM, Shi YZ, Liu MD, Xiao XZ. Heat shock pretreatment inhibited the release of Smac/DIABLO from mitochondria and apoptosis induced by hydrogen peroxide in cardiomyocytes and C2C12 myogenic cells. Cell Stress Chaperones. 2005; 10: 252-62.
37. Cui XJ, Wang HJ, Guo HD, Wang C, Ao H, Liu XQ, et al. Transplantation of mesenchymal stem cells preconditioned with diazoxide, a mitochondrial ATP-sensitive potassium channel opener promotes repair of myocardial infarction in rats. Tohoku J Exp Med. 2010; 220: 139-47.
38. Niagara MI, Haider HK, Jiang SJ, Ashraf M. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res. 2007; 100: 545-55.
39. Idris NM, Ashraf M, Ahmed RPH, Jiang SJ, Haider KH. Activation of IL-11/STAT3 pathway in preconditioned human skeletal myoblasts blocks apoptotic cascade under oxidant stress. Regen Med. 2012; 7: 47-57.
40. Afzal MR, Haider HK, Idris NM, Jiang SJ, Ahmed RPH, Ashraf M. Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappa B signaling. Antioxid Redox Signal. 2010; 12: 693-702.
41. Li LF, Zeng H, Chen JX. Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction. Am J Physiol Heart Circ Physiol. 2012; 303: 605-18.
42. Kim JH, Oh AY, Choi YM, Ku SY, Kim YY, Lee NJ, et al. Isoflurane decreases death of human embryonic stem cell-derived, transcriptional marker Nkx2. 5(+) cardiac progenitor cells. Acta Anaesthesiol Scand. 2011; 55: 1124-31.
43. Yao YW, Zhang FM, Wang LS, Zhang GH, Wang ZJ, Chen JM, et al. Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction. J Biomed Sci. 2009; 16: 11.
44. Cai C, Teng L, Vu D, He J-Q, Guo Y, Li Q, et al. The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release. J Biol Chem. 2012; 287: 33720-32.
45. Haider HK, Ashraf M. Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol. 2008; 45: 554-66.
46. Haider HK, Ashraf M. Preconditioning and stem cell survival. J Cardiovasc Transl Res. 2010; 3: 89-102.
47. Liu HB, Xue WJ, Ge GQ, Luo XH, Li Y, Xiang HL, et al. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1 alpha in MSCs. Biochem Biophys Res Commun. 2010; 401: 509-15.
48. Zeng XJ, Yu SP, Taylor T, Ogle M, Wei L. Protective effect of apelin on cultured rat bone marrow mesenchymal stem cells against apoptosis. Stem Cell Res. 2012; 8: 357-67.
49. Wisel S, Khan M, Kuppusamy ML, Mohan IK, Chacko SM, Rivera BK, et al. Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-2, 3, 4-trimethoxybenzyl piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression. J Pharmacol Exp Ther. 2009; 329: 543-50.
50. Choi KE, Hall CL, Sun JM, Wei L, Mohamad O, Dix TA, et al. A novel stroke therapy of pharmacologically induced hypothermia after focal cerebral ischemia in mice. FASEB J. 2012; 26: 2799-810.
51. Ogle ME, Gu XH, Espinera AR, Wei L. Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia inducible factor-1 alpha. Neurobiol Dis. 2012; 45: 733-42.
52. Semenza GL. Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim Biophys Acta-Mol Cell Res. 2011; 1813: 1263-8.
53. Dehne N, Brune B. HIF-1 in the inflammatory microenvironment. Exp Cell Res. 2009; 315: 1791-7.
54. Greer SN, Metcalf JL, Wang Y, Ohh M. The updated biology of hypoxia-inducible factor. EMBO J. 2012; 31: 2448-60.
55. Valsecchi V, Pignataro G, Del Prete A, Sirabella R, Matrone C, Boscia F, et al. NCX1 is a novel target gene for hypoxia-inducible factor-1 in ischemic brain preconditioning. Stroke. 2011; 42: 754-63.
56. Keogh CL, Yu SP, Wei L. The effect of recombinant human erythropoietin on neurovasculature repair after focal ischemic stroke in neonatal rats. J Pharmacol Exp Ther. 2007; 322: 521-8.
57. Li WL, Fraser JL, Yu SP, Zhu J, Jiang YJ, Wei L. The role of VEGF/VEGFR2 signaling in peripheral stimulation-induced cerebral neurovascular regeneration after ischemic stroke in mice. Exp Brain Res. 2011; 214: 503-13.
58. Li WL, Yu SP, Ogle ME, Ding XS, Wei L. Enhanced neurogenesis and cell migration following focal ischemia and peripheral stimulation in mice. Dev Neurobiol. 2008; 68: 1474-86.
59. Whitaker VR, Cui L, Miller S, Yu SP, Wei L. Whisker stimulation enhances angiogenesis in the barrel cortex following focal ischemia in mice. J Cereb Blood Flow Metab. 2007; 27: 57-68.
60. Peng H, Wu Y, Duan Z, Ciborowski P, Zheng JC. Proteolytic processing of SDF-1alpha by matrix metalloproteinase-2 impairs CXCR4 signaling and reduces neural progenitor cell migration. Protein Cell. 2012; 3: 875-82.
61. Mahfoudh-Boussaid A, Zaouali MA, Hadj-Ayed K, Miled AH, Saidane-Mosbahi D, Rosello-Catafau J, et al. Ischemic preconditioning reduces endoplasmic reticulum stress and upregulates hypoxia inducible factor-1 alpha in ischemic kidney: the role of nitric oxide. J Biomed Sci. 2011; 19: 8.
62. Robinson MA, Baumgardner JE, Otto CM. Oxygen-dependent regulation of nitric oxide production by inducible nitric oxide synthase. Free Radic Biol Med. 2011; 51: 1952-65.
63. Liu XB, Wang JA, Ogle ME, Wei L. Prolyl hydroxylase inhibitor dimethyloxalylglycine enhances mesenchymal stem cell survival. J Cell Biochem. 2009; 106: 903-11.
64. Sims B, Clarke M, Francillion L, Kindred E, Hopkins ES, Sontheimer H. Hypoxic preconditioning involves system Xc(-) regulation in mouse neural stem cells. Stem Cell Res. 2012; 8: 285-91.
65. Shih AY, Erb H, Sun X, Toda S, Kalivas PW, Murphy TH. Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J Neurosci. 2006; 26: 10514-23.
66. Cerrada, I, Ruiz-Sauri, A, Carrero, R, Trigueros, C, Dorronsoro, A, Sanchez-Puelles, JM, Diez-Juan, A, Montero, JA, Sepulveda, P. Hypoxia-inducible factor 1 alpha contributes to cardiac healing in mesenchymal stem cells-mediated cardiac repair. Stem Cells Dev. 2012; (in press).
67. Park J, Park H-H, Choi H, Seo Kim Y, Yu H-J, Lee K-Y, et al. Coenzyme Q10 protects neural stem cells against hypoxia by enhancing survival signals. Brain Res. 2012; 1478: 64-73.
68. Dirnagl U, Meisel A. Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning. Neuropharmacology. 2008; 55: 334-44.
69. Ravati A, Ahlemeyer B, Becker A, Klumpp S, Krieglstein J. Preconditioning-induced neuroprotection is mediated by reactive oxygen species and activation of the transcription factor nuclear factor-kappa B. J Neurochem. 2001; 78: 909-19.
70. Jou MJ. Pathophysiological and pharmacological implications of mitochondria-targeted reactive oxygen species generation in astrocytes. Adv Drug Deliv Rev. 2008; 60: 1512-26.
71. 2 in PC12 cells: mechanisms via MMP, ROS, and Bcl-2. Brain Res. 2005; 1057: 57-64.
72. Xiao L, Lan A, Mo L, Xu W, Jiang N, Hu F, et al. Hydrogen sulfide protects PC12 cells against reactive oxygen species and extracellular signal-regulated kinase 1/2-mediated downregulation of glutamate transporter-1 expression induced by chemical hypoxia. Int J Mol Med. 2012; 30: 1126-32.
73. Waszak P, Alphonse R, Vadivel A, Ionescu L, Eaton F, Thebaud B. Preconditioning enhances the paracrine effect of mesenchymal stem cells in preventing oxygen-induced neonatal lung injury in rats. Stem Cells Dev. 2012; 21: 2789-97.
74. Furuichi T, Liu WL, Shi HL, Miyake M, Liu KJ. Generation of hydrogen peroxide during brief oxygen-glucose deprivation induces preconditioning neuronal protection in primary cultured neurons. J Neurosci Res. 2005; 79: 816-24.
75. Sakata H, Niizuma K, Yoshioka H, Kim GS, Jung JE, Katsu M, et al. Minocycline-preconditioned neural stem cells enhance neuroprotection after ischemic stroke in rats. J Neurosci. 2012; 32: 3462-73.
76. Seidlmayer LK, Gomez-Garcia MR, Blatter LA, Pavlov E, Dedkova EN. Inorganic polyphosphate is a potent activator of the mitochondrial permeability transition pore in cardiac myocytes. J Gen Physiol. 2012; 139: 321-31.
77. Abramov AY, Fraley C, Diao CT, Winkfein R, Colicos MA, Duchen MR, et al. Targeted polyphosphatase expression alters mitochondrial metabolism and inhibits calcium-dependent cell death. Proc Natl Acad Sci U S A. 2007; 104: 18091-6.
78. Wang JA, Chen TL, Jiang J, Shi H, Gui C, Luo RH, et al. Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. Acta Pharmacol Sin. 2008; 29: 74-82.
79. Sepac A, Sedlic F, Si-Tayeb K, Lough J, Duncan SA, Bienengraeber M, et al. Isoflurane preconditioning elicits competent endogenous mechanisms of protection from oxidative stress in cardiomyocytes derived from human embryonic stem cells. Anesthesiology. 2010; 113: 906-16.
80. 2+ -activated potassium channels in adenosine A(1) receptor-mediated pharmacological preconditioning in H9c2 cells. Eur J Pharmacol. 2009; 618: 37-44.
81. Simerabet M, Robin E, Aristi I, Adamczyk S, Tavernier B, Vallet B, et al. Preconditioning by an in situ administration of hydrogen peroxide: involvement of reactive oxygen species and mitochondrial ATP-dependent potassium channel in a cerebral ischemia-reperfusion model. Brain Res. 2008; 1240: 177-84.
82. Sheng R, Liu XQ, Zhang LS, Gao B, Han R, Wu YQ, et al. Autophagy regulates endoplasmic reticulum stress in ischemic preconditioning. Autophagy. 2012; 8: 310-25.
83. Park HK, Chu K, Jung KH, Lee ST, Bahn JJ, Kim M, et al. Autophagy is involved in the ischemic preconditioning. Neurosci Lett. 2009; 451: 16-9.
84. Yeh CH, Hsu SP, Yang CC, Chien CT, Wang NP. Hypoxic preconditioning reinforces HIF-alpha-dependent HSP70 signaling to reduce ischemic renal failure-induced renal tubular apoptosis and autophagy. Life Sci. 2010; 86: 115-23.
85. Rodriguez-Sinovas A, Boengler K, Cabestrero A, Gres P, Morente M, Ruiz-Meana M, et al. Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection. Circ Res. 2006; 99: 93-101.
86. Fontes MSC, van Veen LAB, de Bakker JMT, van Rijen HVM. Functional consequences of abnormal Cx43 expression in the heart. Biochim Biophys Acta-Biomembr. 2012; 1818: 2020-9.
87. Axelsen LN, Stahlhut M, Mohammed S, Larsen BD, Nielsen MS, Holstein-Rathlou NH, et al. Identification of ischemia-regulated phosphorylation sites in connexin43: a possible target for the antiarrhythmic peptide analogue rotigaptide (ZP123). J Mol Cell Cardiol. 2006; 40: 790-8.
88. Lu G, Haider HK, Jiang SJ, Ashraf M. Sca-1(+) stem cell survival and engraftment in the infarcted heart dual role for preconditioning-induced connexin-43. Circulation. 2009; 119: 2587-96.
89. Orellana JA, Froger N, Ezan P, Jiang JX, Bennett MVL, Naus CC, et al. ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J Neurochem. 2011; 118: 826-40.
90. Lin JHC, Lou N, Kang N, Takano T, Hu F, Han XN, et al. A central role of connexin 43 in hypoxic preconditioning. J Neurosci. 2008; 28: 681-95.
91. Jaderstad J, Brismar H, Herlenius E. Hypoxic preconditioning increases gap-junctional graft and host communication. Neuroreport. 2010; 21: 1126-32.
92. Lu G, Jiang SJ, Ashraf M, Haider KH. Subcellular preconditioning of stem cells: mito-Cx43 gene targeting is cytoprotective via shift of mitochondrial Bak and Bcl-xL balance. Regen Med. 2012; 7: 323-34.
93. Lu G, Haider HK, Porollo A, Ashraf M. Mitochondria-specific transgenic overexpression of connexin-43 simulates preconditioning-induced cytoprotection of stem cells. Cardiovasc Res. 2010; 88: 277-86.
94. Wang DG, Shen WZ, Zhang FX, Chen ML, Chen HW, Cao KJ. Connexin43 promotes survival of mesenchymal stem cells in ischaemic heart. Cell Biol Int. 2010; 34: 415-23.
95. Ahmad Waza A, Andrabi K, Ul Hussain M. Adenosine-triphosphate-sensitive K(+)channel (Kir6. 1): a novel phosphospecific interaction partner of connexin 43 (Cx43). Exp Cell Res. 2012; 318: 2559-66.
96. Rottlaender D, Boengler K, Wolny M, Michels G, Endres-Becker J, Motloch LJ, et al. Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial K-ATP channels in mouse cardiomyocytes. J Clin Investig. 2010; 120: 1441-53.
97. Du WJ, Li JK, Wang QY, Hou JB, Yu B. Lithium chloride preconditioning optimizes skeletal myoblast functions for cellular cardiomyoplasty in vitro via glycogen synthase kinase-3 beta/beta-catenin signaling. Cells Tissues Organs. 2009; 190: 11-9.
98. Sierra MD, Yang FQ, Narazaki M, Salvucci O, Davis D, Yarchoan R, et al. Differential processing of strornal-derived factor-1 alpha and stromal-derived factor-1 beta explains functional diversity. Blood. 2004; 103: 2452-9.
99. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 2002; 3: 687-94.
100. Sharma M, Afrin F, Satija N, Tripathi RP, Gangenahalli GU. Stromal-derived factor-1/CXCR4 signaling: indispensable role in homing and engraftment of hematopoietic stem cells in bone marrow. Stem Cells Dev. 2011; 20: 933-46.
101. Zhao DH, Najbauer J, Garcia E, Metz MZ, Gutova M, Glackin CA, et al. Neural stem cell tropism to glioma: critical role of tumor hypoxia. Mol Cancer Res. 2008; 6: 1819-29.
102. Hung SC, Pochampally RR, Hsu SC, Sanchez C, Chen SC, Spees J, et al. Short-term exposure of multipotent stromal cells to low oxygen increases their expression of cx3cr1 and cxcr4 and their engraftment in vivo. PLoS One. 2007; 2: 11.
103. Kubo M, Li TS, Kamota T, Ohshima M, Qin SL, Hamano K. Increased expression of CXCR4 and integrin alpha m in hypoxia-preconditioned cells contributes to improved cell retention and angiogenic potency. J Cell Physiol. 2009; 220: 508-14.
104. Tang YL, Zhu WQ, Cheng M, Chen LJ, Zhang J, Sun T, et al. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res. 2009; 104: 1209-U218.
105. Cencioni C, Capogrossi MC, Napolitano M. The SDF-1/CXCR4 axis in stem cell preconditioning. Cardiovasc Res. 2012; 94: 400-7.
106. Ong LL, Li WZ, Oldigs JK, Kaminski A, Gerstmayer B, Piechaczek C, et al. Hypoxic/normoxic preconditioning increases endothelial differentiation potential of human bone marrow cd133+ cells. Tissue Eng Part C Methods. 2010; 16: 1069-81.
107. Lin JS, Chen YS, Chiang HS, Ma MC. Hypoxic preconditioning protects rat hearts against ischaemia-reperfusion injury: role of erythropoietin on progenitor cell mobilization. J Physiol-Lond. 2008; 586: 5757-69.
108. Miller JT, Bartley JH, Wimborne HJC, Walker AL, Hess DC, Hill WD, et al. The neuroblast and angioblast chemotaxic factor SDF-1 (CXCL12) expression is briefly up regulated by reactive astrocytes in brain following neonatal hypoxic-ischemic injury. BMC Neurosci. 2005; 6: 11.
109. Gao H, Priebe W, Glod J, Banerjee D. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium. Stem Cells. 2009; 27: 857-65.
110. Zheng H, Fu GS, Dai T, Huang H. Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1 alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol. 2007; 50: 274-80.
111. Kim HW, Mallick F, Durrani S, Ashraf M, Jiang SJ, Haider KH. Concomitant activation of mir-107/pdcd10 and hypoxamir-210/casp8ap2 and their role in cytoprotection during ischemic preconditioning of stem cells. Antioxid Redox Signal. 2012; 17: 1053-65.
112. Meng S, Cao JT, Wang LS, Zhou Q, Li YG, Shen CX, et al. Microrna 107 partly inhibits endothelial progenitor cells differentiation via hif-1 beta. PLoS One. 2012; 7: 7.
113. Suzuki Y, Kim HW, Ashraf M, Haider HK. Diazoxide potentiates mesenchymal stem cell survival via NF-kappa B-dependent miR-146a expression by targeting fas. Am J Physiol Heart Circ Physiol. 2010; 299: H1077-82.
114. Kostjuk S, Loseva P, Chvartatskaya O, Ershova E, Smirnova T, Malinovskaya E, et al. Extracellular GC-rich DNA activates TLR9-and NF-kB-dependent signaling pathways in human adipose-derived mesenchymal stem cells (haMSCs). Expert Opin Biol Ther. 2012; 12: S99-111.
115. Francis KR, Wei L. Human embryonic stem cell neural differentiation and enhanced cell survival promoted by hypoxic preconditioning. Cell Death Dis. 2010; 1: 11.
116. Lin C, Jun J, Ling W, Xin Z, Fraser JL, Snider BJ, et al. Transplantation of embryonic stem cells improves nerve repair and functional recovery after severe sciatic nerve axotomy in rats. Stem Cells. 2008; 26: 1356-65.
117. Khan M, Akhtar S, Mohsin S, Khan SN, Riazuddin S. Growth factor preconditioning increases the function of diabetes-impaired mesenchymal stem cells. Stem Cells Dev. 2011; 20: 67-75.
118. Hoke NN, Salloum FN, Kass DA, Das A, Kukreja RC. Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice. Stem Cells. 2012; 30: 326-35.
119. Herrmann JL, Wang Y, Abarbanell AM, Weil BR, Tan JN, Meldrum DR. Preconditiong mesenchymal stem cells with transforming growth factor-α improves mesenchymal stem cell-mediated cardioprotection. Shock. 2010; 33: 24-30.
120. Efimenko A, Starostina E, Kalinina N, Stolzing A. Angiogenic properties of aged adipose derived mesenchymal stem cells after hypoxic conditioning. J Transl Med. 2011; 9: 13.
121. Chang C-P, Chio C-C, Cheong C-U, Chao C-M, Cheng B-C, Lin M-T. Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury. Clin Sci (Lond). 2013; 124: 165-76.
122. Mohamad O, Chen DD, Zhang LL, Hofmann C, Wei L, Yu SP. Erythropoietin reduces neuronal cell death and hyperalgesia induced by peripheral inflammatory pain in neonatal rats. Mol Pain. 2011; 7: 15.
123. Li JM, Li JP, Zhang X, Lu ZY, Yu SP, Wei L. Expression of heparanase in vascular cells and astrocytes of the mouse brain after focal cerebral ischemia. Brain Res. 2012; 1433: 137-44.
124. Hu X, Wei L, Taylor TM, Wei J, Zhou X, Wang J-A, et al. Hypoxic preconditioning enhances bone marrow mesenchymal stem cell migration via Kv2. 1 channel and FAK activation. Am J Physiol Cell Physiol. 2011; 301: C362-72.
125. Kamota T, Li TS, Morikage N, Murakami M, Ohshima M, Kubo M, et al. Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. J Am Coll Cardiol. 2009; 53: 1814-22.
126. Li SY, Deng YB, Feng JQ, Ye WB. Oxidative preconditioning promotes bone marrow mesenchymal stem cells migration and prevents apoptosis. Cell Biol Int. 2009; 33: 411-8.
127. Rosova I, Dao M, Capoccia B, Link D, Nolta JA. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells. 2008; 26: 2173-82.
128. Hayakawa J, Migita M, Ueda T, Fukazawa R, Adachi K, Ooue Y, et al. Dextran sulfate and stromal cell derived factor-1 promote cxcr4 expression and improve bone marrow homing efficiency of infused hematopoietic stem cells. J Nippon Med School. 2009; 76: 198-208.
129. Wei J-F, Wei L, Zhou X, Lu Z-Y, Francis K, Hu X-Y, et al. Formation of Kv2. 1-FAK complex as a mechanism of FAK activation, cell polarization and enhanced motility. J Cell Physiol. 2008; 217: 544-57.
130. Wei, J-F, Wei, L, Zhou, X, Lu, Z-Y, Francis, K, Hu, X-Y, Liu, Y, Xiong, W-C, Zhang, X, Banik, NL, Zheng, S-S, Yu, SP. Formation of Kv2. 1-FAK complex as a mechanism of FAK activation, cell polarization and enhanced motility. J Cell Physiol. 2008; 217(2): 544-57.
131. Rota C, Imberti B, Pozzobon M, Piccoli M, De Coppi P, Atala A, et al. Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev. 2012; 21: 1911-23.
132. Gyongyosi M, Posa A, Pavo N, Hemetsberger R, Kvakan H, Steiner-Boker S, et al. Differential effect of ischaemic preconditioning on mobilisation and recruitment of haematopoietic and mesenchymal stem cells in porcine myocardial ischaemia-reperfusion. Thromb Haemost. 2010; 104: 376-84.
133. Czeiger D, Dukhno O, Douvdevani A, Porat Y, Shimoni D, Fulga V, et al. Transient extremity ischemia augments CD34+ progenitor cell availability. Stem Cell Rev Rep. 2011; 7: 639-45.
134. Patschan D, Krupincza K, Patschan S, Zhang ZT, Hamby C, Goligorsky MS. Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioning. Am J Physiol Renal Physiol. 2006; 291: F176-85.
135. Akita T, Murohara T, Ikeda H, Sasaki KI, Shimada T, Egami K, et al. Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Lab Investig. 2003; 83: 65-73.
136. Leroux L, Descamps B, Tojais NF, Seguy B, Oses P, Moreau C, et al. Hypoxia preconditioned mesenchymal stem cells improve vascular and skeletal muscle fiber regeneration after ischemia through a Wnt4-dependent pathway. Mol Ther. 2010; 18: 1545-52.
137. Yamazaki M, Nakamura K, Mizukami Y, Ii M, Sasajima J, Sugiyama Y, et al. Sonic hedgehog derived from human pancreatic cancer cells augments angiogenic function of endothelial progenitor cells. Cancer Sci. 2008; 99: 1131-8.
138. Volkmer E, Kallukalam BC, Maertz J, Otto S, Drosse I, Polzer H, et al. Hypoxic preconditioning of human mesenchymal stem cells overcomes hypoxia-induced inhibition of osteogenic differentiation. Tissue Eng Part A. 2010; 16: 153-64.
139. Morimoto D, Tomita T, Kuroda S, Higuchi C, Kato S, Shiba T, et al. Inorganic polyphosphate differentiates human mesenchymal stem cells into osteoblastic cells. J Bone Miner Metab. 2010; 28: 418-23.
140. Kawazoe Y, Katoh S, Onodera Y, Kohgo T, Shindoh M, Shiba T. Activation of the FGF signaling pathway and subsequent induction of mesenchymal stem cell differentiation by inorganic polyphosphate. Int J Biol Sci. 2008; 4: 37-47.
141. Shmelkov SV, Meeus S, Moussazadeh N, Kermani P, Rashbaum WK, Rabbany SY, et al. Cytokine preconditioning promotes codifferentiation of human fetal liver CD133(+) stem cells into angiomyogenic tissue. Circulation. 2005; 111: 1175-83.
142. Cui JH, Park SR, Park K, Choi BH, Min BH. Preconditioning of mesenchymal stem cells with low-intensity ultrasound for cartilage formation in vivo. Tissue Eng. 2007; 13: 351-60.
143. Lucchinetti E, Zeisberger SM, Baruscotti I, Wacker J, Feng JH, Zaugg K, et al. Stem cell-like human endothelial progenitors show enhanced colony-forming capacity after brief sevoflurane exposure: preconditioning of angiogenic cells by volatile anesthetics. Anesth Analg. 2009; 109: 1117-26.
144. Popescu M, Munteanu A, Isvoranu G, Suciu L, Pavel B, Marinescu B, et al. Dynamics of endothelial progenitor cells following sevoflurane preconditioning. Roum Arch Microbiol Immunol. 2011; 70: 109-13.
145. Kubo M, Li TS, Kurazumi H, Takemoto Y, Ohshima M, Murata T, et al. Hypoxic preconditioning enhances angiogenic potential of bone marrow cells with aging-related functional impairment. Circ J. 2012; 76: 986-94.
146. Wang MJ, Tsai BM, Crisostomo PR, Meldrum DR. Pretreatment with adult progenitor cells improves recovery and decreases native myocardial proinflammatory signaling after ischemia. Shock. 2006; 25: 454-9.
147. Bacigaluppi M, Pluchino S, Jametti LP, Kilic E, Kilic U, Salani G, et al. Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain. 2009; 132: 2239-51.
148. Loos B, Smith R, Engelbrecht AM. Ischaemic preconditioning and TNF-alpha-mediated preconditioning is associated with a differential cPLA(2) translocation pattern in early ischaemia. Prostaglandins Leukot Essent Fat Acids. 2008; 78: 403-13.
149. Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells. 2006; 24: 386-98.
150. Cheng AS, Yau TM. Paracrine effects of cell transplantation: strategies to augment the efficacy of cell therapies. Sem Thorac Cardiovasc Surg. 2008; 20: 94-101.
151. Canfield SG, Sepac A, Sedlic F, Muravyeva MY, Bai XW, Bosnjak ZJ. Marked hyperglycemia attenuates anesthetic preconditioning in human-induced pluripotent stem cell-derived cardiomyocytes. Anesthesiology. 2012; 117: 735-44.
152. Zeng XJ, Yu SP, Zhang L, Wei L. Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons. Exp Cell Res. 2010; 316: 1773-83.
153. Ito T, Itakura S, Todorov I, Rawson J, Asari S, Shintaku J, et al. Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function. Transplantation. 2010; 89: 1438-45.
154. Oh JS, Ha Y, An SS, Khan M, Pennant WA, Kim HJ, et al. Hypoxia-preconditioned adipose tissue-derived mesenchymal stem cell increase the survival and gene expression of engineered neural stem cells in a spinal cord injury model. Neurosci Lett. 2010; 472: 215-9.
155. Kim HW, Haider HK, Jiang SJ, Ashraf M. Ischemic preconditioning augments survival of stem cells via mir-210 expression by targeting caspase-8-associated protein 2. J Biol Chem. 2009; 284: 33161-8.
156. Noiseux N, Borie M, Desnoyers A, Menaouar A, Stevens LM, Mansour S, et al. Preconditioning of stem cells by oxytocin to improve their therapeutic potential. Endocrinology. 2012; 153: 5361-72.
157. Chen TL, Wang JA, Shi H, Gui C, Luo RH, Xie XJ, et al. Cyclosporin A pre-incubation attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. Scand J Clin Lab Inv. 2008; 68: 585-93.